Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Growing
The company is in a growing phase, with the latest annual income totaling USD 225.00K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 225.00K.
Overvalued
The company’s latest PE is -0.51, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 12.73M shares, increasing 40.22% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 394.96K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 3.14.